The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial

Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease with inflammatory synovitis. Iguratimod (IGU) combined with methotrexate (MTX) therapy may have better efficacy and safety. Methods: First, we searched randomized controlled trials (RCTs) of IGU + MTX in the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Liuting, Yu, Ganpeng, Yang, Kailin, Hao, Wensa, Chen, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804504/
https://www.ncbi.nlm.nih.gov/pubmed/35115930
http://dx.doi.org/10.3389/fphar.2021.780154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804504/
https://www.ncbi.nlm.nih.gov/pubmed/35115930
http://dx.doi.org/10.3389/fphar.2021.780154

Ejemplares similares